These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 20192585

  • 1. Estrogen receptor, progesterone receptor, HER2/neu, P53 and Ki-67 status of male breast carcinomas in Pakistan.
    Jamal S, Mushtaq H, Mubarik A, Malik TM.
    Asian Pac J Cancer Prev; 2009; 10(6):1067-70. PubMed ID: 20192585
    [Abstract] [Full Text] [Related]

  • 2. Histological and immuno-histochemical study of male breast carcinoma in Northern Pakistan.
    Sharif MA, Mamoon N, Arif A, Mushtaq S, Khadim MT.
    J Pak Med Assoc; 2009 Feb; 59(2):67-71. PubMed ID: 19260565
    [Abstract] [Full Text] [Related]

  • 3. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.
    Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, Shapiro DH.
    Mod Pathol; 2002 Aug; 15(8):853-61. PubMed ID: 12181271
    [Abstract] [Full Text] [Related]

  • 4. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA, Mamoon N, Mushtaq S, Khadim MT.
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
    [Abstract] [Full Text] [Related]

  • 5. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I, Makovitzky J, Jeschke U, Briese V, Friese K, Gerber B.
    Anticancer Res; 2005 Feb; 25(3A):1719-23. PubMed ID: 16033090
    [Abstract] [Full Text] [Related]

  • 6. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y.
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
    Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G.
    Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
    [Abstract] [Full Text] [Related]

  • 8. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.
    Zhu X, Ying J, Wang F, Wang J, Yang H.
    Breast Cancer Res Treat; 2014 Oct; 147(3):551-5. PubMed ID: 25234844
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa, Bhurgri Y, Raza F, Kayani N.
    Asian Pac J Cancer Prev; 2008 Oct; 9(4):553-6. PubMed ID: 19256737
    [Abstract] [Full Text] [Related]

  • 11. Interrelationships Between Ki67, HER2/neu, p53, ER, and PR Status and Their Associations With Tumor Grade and Lymph Node Involvement in Breast Carcinoma Subtypes: Retrospective-Observational Analytical Study.
    Shokouh TZ, Ezatollah A, Barand P.
    Medicine (Baltimore); 2015 Aug; 94(32):e1359. PubMed ID: 26266392
    [Abstract] [Full Text] [Related]

  • 12. Histological and immunohistochemical features of medullary breast cancer.
    Romaniuk A, Lyndin M, Sikora V, Lyndina Y, Panasovska K.
    Folia Med Cracov; 2015 Aug; 55(2):41-8. PubMed ID: 26839242
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ki-67 is a prognostic marker for hormone receptor positive tumors.
    Pérez-López ME, García-Gómez J, Alves MT, Paradela A, García-Mata J, García-Caballero T.
    Clin Transl Oncol; 2016 Oct; 18(10):996-1002. PubMed ID: 26742937
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Correlations between HER2 Expression and Other Prognostic Factors in Breast Cancer: Inverse Relations with the Ki-67 Index and P53 Status.
    Payandeh M, Shahriari-Ahmadi A, Sadeghi M, Sadeghi E.
    Asian Pac J Cancer Prev; 2016 Oct; 17(3):1015-8. PubMed ID: 27039719
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ductal invasive mammary carcinoma--clinicopathological prognostic factors related to immunohistochemical expression of hormonal receptors and Her2/neu oncoprotein.
    Recăreanu F, Simionescu C, Georgescu CV, Pirici E.
    Rom J Morphol Embryol; 2011 Oct; 52(3 Suppl):1059-64. PubMed ID: 22119825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.